FINWIRES · TerminalLIVE
FINWIRES

NZE:AFT

5 stories mentioning NZE:AFT

Every FINWIRES story that references NZE:AFT, newest first.

Asia

NZX Biggest Losers

Here are the NZX-listed companies with the biggest losses on Friday.Manuka Resources (NZE:MKR): -8%, NZ$0.10Black Pearl Group (NZE:BPG): -2%, NZ$0.62The Warehouse Group (NZE:WHS): -2%, NZ$0.62Gentrack Group (NZE:GTK): -2%, NZ$3.75Pacific Edge (NZE:PEB): -2%, NZ$0.30Hallenstein Glasson Holdings (NZE:HLG): -1%, NZ$10.01AFT Pharmaceuticals (NZE:AFT): -1%, NZ$3.88Air New Zealand (NZE:AIR): -1%, NZ$0.41SkyCity Entertainment Group (NZE:SKC): -1%, NZ$0.46PGG Wrightson (NZE:PGW): -1%, NZ$2.08

^NZ50NZE:AFTNZE:AIRNZE:BPGNZE:GTKNZE:HLGNZE:MKRNZE:PEBNZE:PGWNZE:SKCNZE:WHS
Asia

Update: AFT Pharmaceuticals Posts Higher Fiscal 2026 Earnings, Revenue; Shares Reach Three-Year High

(Update to add stock movement in the headline and fifth paragraph)AFT Pharmaceuticals (ASX:AFP, NZE:AFT) reported Thursday fiscal 2026 earnings of NZ$0.14 per share, up from NZ$0.11 a year earlier.Revenue for the 12 months ended March 31 was NZ$254.7 million, compared with NZ$208 million a year earlier.The company expects to continue its growth trajectory in fiscal 2027 as it works toward achieving its revenue target of at least NZ$300 million, with operating profit projected to range between NZ$28 million and NZ$32 million.The board declared a final dividend of NZ$0.025 per share, up from NZ$0.018 a year earlier, payable July 3 to shareholders on record as of June 19.Its shares rose over 11% in recent trading on the Australian bourse and over 9% on the New Zealand bourse, reaching an over three-year high.

ASX:AFPNZE:AFT
Asia

AFT Pharmaceuticals Posts Higher Fiscal 2026 Earnings, Revenue

AFT Pharmaceuticals (ASX:AFP, NZE:AFT) reported Thursday fiscal 2026 earnings of NZ$0.14 per share, up from NZ$0.11 a year earlier.Revenue for the 12 months ended March 31 was NZ$254.7 million, compared with NZ$208 million a year earlier.The company expects to continue its growth trajectory in fiscal 2027 as it works toward achieving its revenue target of at least NZ$300 million, with operating profit projected to range between NZ$28 million and NZ$32 million.The board declared a final dividend of NZ$0.025 per share, up from NZ$0.018 a year earlier, payable July 3 to shareholders on record as of June 19.

ASX:AFPNZE:AFT
Asia

New Zealand Shares Fall; AFT Pharmaceuticals Appoints CFO

New Zealand shares ended lower on Monday as all Asian shares saw losses after fresh drone attacks in the Gulf region.The S&P/NZX 50 Index fell 1.56% or 202.09 points to close at 12,762.92.A drone strike caused a fire in a nuclear power plant in the United Arab Emirates on Sunday, while Saudi Arabia said it intercepted three drones, according to a Sunday report by Reuters.In domestic news, New Zealand's services sector showed a modest improvement in April but remained in contraction, with persistent cost pressures and global shipping disruptions continuing to weigh on sentiment, according to a statement by BusinessNZ.In corporate news, AFT Pharmaceuticals (ASX:AFP, NZE:AFT) appointed Stuart Houliston as chief financial officer, effective June 15.Gentrack Group (NZE:GTK, ASX:GTK) acquired New Zealand software-as-a-service company Prospero Energy, trading as Factor, in a deal valued at NZ$24 million.

^NZ50ASX:AFPASX:GTKNZE:AFTNZE:GTK
Asia

AFT Pharmaceuticals Appoints CFO

AFT Pharmaceuticals (ASX:AFP, NZE:AFT) appointed Stuart Houliston as chief financial officer, effective June 15, according to a Monday filing with the Australian and New Zealand bourses.Houliston will succeed Malcolm Tubby after his retirement on May 29, with Simon Bosley taking on the role in the interim period, per the filing.Houliston will be joining the company from Sanford (NZE:SAN), the filing added.

ASX:AFPNZE:AFTNZE:SAN